We have identified a list of several trending healthtech stocks that appear have recently received buy ratings from top Wall Street analysts and are showing positive investor sentiment, as well as news headlines. With that said, our editors here at healthtechmovers.com, are adding these healthtech companies to our watchlist to see if this momentum continues. Our watchlist includes trending
Summary: Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK.
- Recent INBS Stock Price: $1.20
- Yearly Gain for INBS stock: -11.21%
- Market Cap for INBS stock: $4.81M
- P/E Ratio for INBS stock: -0.482
Will INBS's stock price go up? Is there an accurate INBS stock forecast available?
TipRanks.com reports that Intelligent Bio Solutions currently has n/a analysts offering 12-month price targets and the consensus is a n/a rating with an average price target is n/a. The target pricing ranges from a high INBS forecast of n/a down to a low forecast of n/a. Intelligent Bio Solutions (INBS)’s last closing stock price was $1.20 which would put the average price target at {Analyst Price Target - upside/downside} upside.
In addition, TradingView issued a Strong Buy rating for INBS stock over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on INBS stock.
If you are wondering if INBS is a good stock to buy, here are 3rd party ratings for INBS stock:
- TipRanks.com: n/a
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: n/a, n/a
What is the sentiment on the street regarding Intelligent Bio Solutions? (Current ratings compiled by TipRanks.com)
- News Sentiment for INBS stock: Very Bullish
- Blogger Consensus for INBS stock: ―
- Media Buzz for INBS stock: Very High
- Insider Signal for INBS stock: ―
- Investor Sentiment for INBS stock: Very Negative
- Hedge Fund signal for INBS stock: Neutral
The stock market is extremely volatile, and you need to do your own research on INBS stock including scouring the social networks like INBS StockTwits, Twitter and Reddit before you decide to make any investment.
Click here for INBS stock chart >>
Summary: DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States.
- Recent DMTK Stock Price: $6.10
- Yearly Gain for DMTK stock: -63.46%
- Market Cap for DMTK stock: $136.57M
- P/E Ratio for DMTK stock: -1.18
Will DMTK's stock price go up? Is there an accurate DMTK stock forecast available?
TipRanks.com reports that DermTech currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $6.25. The target pricing ranges from a high DMTK forecast of $8.00 down to a low forecast of $5.00. DermTech (DMTK)’s last closing stock price was $6.10 which would put the average price target at {Analyst Price Target - upside/downside} upside.
In addition, TradingView issued a Buy rating for DMTK stock over the next month, Barchart.com has a Weak buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on DMTK stock.
If you are wondering if DMTK is a good stock to buy, here are 3rd party ratings for DMTK stock:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Bottom 33% (169 out of 251)
What is the sentiment on the street regarding DermTech? (Current ratings compiled by TipRanks.com)
- News Sentiment for DMTK stock: Very Bearish
- Blogger Consensus for DMTK stock: Bullish
- Media Buzz for DMTK stock: Low
- Insider Signal for DMTK stock: Negative
- Investor Sentiment for DMTK stock: Neutral
- Hedge Fund signal for DMTK stock: Negative
The stock market is extremely volatile, and you need to do your own research on DMTK stock including scouring the social networks like DMTK StockTwits, Twitter and Reddit before you decide to make any investment.
Click here for DMTK stock chart >>
Summary: NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.
- Recent NPCE Stock Price: $3.47
- Yearly Gain for NPCE stock: -67.92%
- Market Cap for NPCE stock: $74.21M
- P/E Ratio for NPCE stock: -1.754
Will NPCE's stock price go up? Is there an accurate NPCE stock forecast available?
TipRanks.com reports that NeuroPace currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.25. The target pricing ranges from a high NPCE forecast of $6.00 down to a low forecast of $2.50. NeuroPace (NPCE)’s last closing stock price was $3.47 which would put the average price target at {Analyst Price Target - upside/downside} upside.
In addition, TradingView issued a Buy rating for NPCE stock over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on NPCE stock.
If you are wondering if NPCE is a good stock to buy, here are 3rd party ratings for NPCE stock:
- TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 37% (93 out of 251)
What is the sentiment on the street regarding NeuroPace? (Current ratings compiled by TipRanks.com)
- News Sentiment for NPCE stock: ―
- Blogger Consensus for NPCE stock: ―
- Media Buzz for NPCE stock: ―
- Insider Signal for NPCE stock: Positive
- Investor Sentiment for NPCE stock: ―
- Hedge Fund signal for NPCE stock: No Signal
The stock market is extremely volatile, and you need to do your own research on NPCE stock including scouring the social networks like NPCE StockTwits, Twitter and Reddit before you decide to make any investment.
Click here for NPCE stock chart >>
Summary: Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.
- Recent BIOR Stock Price: $4.44
- Yearly Gain for BIOR stock: -87.41%
- Market Cap for BIOR stock: $30.69M
- P/E Ratio for BIOR stock: -0.232
Will BIOR's stock price go up? Is there an accurate BIOR stock forecast available?
TipRanks.com reports that Biora Therapeutics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $65.00. The target pricing ranges from a high BIOR forecast of $65.00 down to a low forecast of $65.00. Biora Therapeutics (BIOR)’s last closing stock price was $4.44 which would put the average price target at {Analyst Price Target - upside/downside} upside.
In addition, TradingView issued a Neutral rating for BIOR stock over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook. Remember, securities are volatile, so please do your own research on BIOR stock.
If you are wondering if BIOR is a good stock to buy, here are 3rd party ratings for BIOR stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Neutral
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 33% (84 out of 251)
What is the sentiment on the street regarding Biora Therapeutics? (Current ratings compiled by TipRanks.com)
- News Sentiment for BIOR stock: Neutral
- Blogger Consensus for BIOR stock: Bullish
- Media Buzz for BIOR stock: Low
- Insider Signal for BIOR stock: ―
- Investor Sentiment for BIOR stock: Neutral
- Hedge Fund signal for BIOR stock: Neutral
The stock market is extremely volatile, and you need to do your own research on BIOR stock including scouring the social networks like BIOR StockTwits, Twitter and Reddit before you decide to make any investment.
Click here for BIOR stock chart >>
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================